EDIVOXETINE HYDROCHLORIDE
UNII CP012282EU

Substance Identification & Data

This profile provides standardized clinical and technical data for Edivoxetine Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CP012282EU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1194374-05-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CP012282EU

CAS Registry Number

1194374-05-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EDIVOXETINE HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H26FNO4.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WJDKGRLMNSHPON-CJRXIRLBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171707

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

56841862

Unique identification number in the NCBI database of chemical substances.

USAN ID

UU-109

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@](Cc1c(ccc(c1)F)OC)(C2CCOCC2)([C@@]3(CNCCO3)[H])O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Edivoxetine Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.